Literature DB >> 3139711

Gamma heavy chain disease in man. Genomic sequence reveals two noncontiguous deletions in a single gene.

A Alexander1, I Anicito, J Buxbaum.   

Abstract

A genomic clone was isolated from a human lymphoid cell line which synthesized an NH2-terminally deleted gamma 3 heavy chain disease protein. Nucleotide sequence analysis revealed a normal sequence from 310 bp 5' to the initiator ATG through the codon for VH amino acid 14. Amino acid 15 was derived from the codon for the last J4 amino acid. Thus, the clone contained a deletion of the codons for the VH region beyond amino acid 14, as well as those for the entire D region and most of the J coding region. Some sequence abnormalities were observed in the 400 bp after the deletion. Beyond this, there was excellent homology to published J and intervening sequences, including those containing the enhancer elements. The 1,200-bp switch region was abruptly interrupted by a sequence corresponding to the 3' one-third of CH1. Thus, a second deletion eliminated the acceptor splice site at the 5' end of CH1. When splicing of the primary RNA transcript occurred, the truncated VH region was joined via the J4 donor splice site to the next available acceptor site 5' to the first hinge exon. Hence, the aberrant serum protein was the product of two deletions and a splice correction as well as postsynthetic NH2-terminal proteolysis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139711      PMCID: PMC442675          DOI: 10.1172/JCI113722

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  The molecular defect in a protein (CRA) found in gamma-1 heavy chain disease, and its genetic implications.

Authors:  E C Franklin; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1971-01       Impact factor: 11.205

2.  Implications of heavy chain disease protein sequences for multiple gene theories of immunoglobulin synthesis.

Authors:  W D Terry; J Ohms
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

3.  A gamma l heavy-chain disease protein *EST) lacking the entire VH and CHl domains.

Authors:  J Biewenga; B Frangione; E C Franklin; E van Loghem
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

4.  delta-Heavy chain disease. A study of a case.

Authors:  J A Vilpo; K Irjala; M K Viljanen; P Klemi; I Kouvonen; T Rönnemaa
Journal:  Clin Immunol Immunopathol       Date:  1980-12

5.  Cloning and partial nucleotide sequence of human immunoglobulin mu chain cDNA from B cells and mouse-human hybridomas.

Authors:  T W Dolby; J Devuono; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

6.  Primary structure of human gamma 3 immunoglobulin deletion mutant: gamma 3 heavy-chain disease protein Wis.

Authors:  B Frangione; E Rosenwasser; F Prelli; E C Franklin
Journal:  Biochemistry       Date:  1980-09-02       Impact factor: 3.162

7.  Gamma heavy chain disease protein CHA: immunological and structural studies.

Authors:  P Arnaud; A C Wang; E Gianazza; I Y Wang; Y Lasne; R Creyssel; H H Fudenberg
Journal:  Mol Immunol       Date:  1981-05       Impact factor: 4.407

Review 8.  The diverse picture of gamma heavy-chain disease. Report of seven cases and review of literature.

Authors:  R A Kyle; P R Greipp; P M Banks
Journal:  Mayo Clin Proc       Date:  1981-07       Impact factor: 7.616

9.  Cloning of human immunoglobulin mu gene and comparison with mouse mu gene.

Authors:  N Takahashi; S Nakai; T Honjo
Journal:  Nucleic Acids Res       Date:  1980-12-20       Impact factor: 16.971

10.  gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model.

Authors:  A Alexander; M Steinmetz; D Barritault; B Frangione; E C Franklin; L Hood; J N Buxbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

View more
  6 in total

1.  Cloning, expression and localization of an RNA helicase gene from a human lymphoid cell line with chromosomal breakpoint 11q23.3.

Authors:  D Lu; J J Yunis
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

2.  Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease.

Authors:  T Goossens; U Klein; R Küppers
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

3.  Immunoglobulin heavy-chain-associated amyloidosis.

Authors:  M Eulitz; D T Weiss; A Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  An aberrant splicing using a 3' cryptic splice site within the CH1 exon induces truncated mu-chain production.

Authors:  T Komori; H Sugiyama
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

5.  Production of Autoreactive Heavy Chain-Only Antibodies in Systemic Lupus Erythematosus.

Authors:  Shu Xu; Hong Yang; Yue Zhuo; Yangsheng Yu; Hongyan Liao; Song Li; Yinshi Yue; Kaihong Su; Zhixin Zhang
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

6.  Two Cases of γ-Heavy Chain Disease and a Review of the Literature.

Authors:  I Ramasamy; Z Rudzki
Journal:  Case Rep Hematol       Date:  2018-08-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.